Get started
Author

Luca Frison

Observed names: L FRISON, L Frison, L. Frison
ORCID: 0000-0001-8445-9318
Observed ORCID: 0000-0001-8445-9318
OpenAlex ID: A5018270348
INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia
2021 · Giovanni Martinelli, Cristina Papayannidis, et al. · Blood Advances · 80
PDF
First Report of the Gimema LAL1811 Phase II Prospective Study of the Combination of Steroids with Ponatinib As Frontline Therapy of Elderly or Unfit Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
2017 · Giovanni Martinelli, Alfonso Piciocchi, et al. · Blood · 70
Lymphoblastic Lymphoma: a Concise Review
2022 · Tamara Intermesoli, Alessandra Weber, et al. · Current Oncology Reports · 60
Co-administration of sirolimus alters tacrolimus pharmacokinetics in a dose-dependent manner in adult renal transplant recipients
2006 · N BALDAN, P RIGOTTI, et al. · Pharmacological Research · 27
Predictive Factors of Stable Deep Molecular Response in Chronic Myeloid Leukemia Patients Treated with Imatinib Standard Dose: A Study from the Gruppo Triveneto LMC
2015 · Massimiliano Bonifacio, Luigi Scaffidi, et al. · Blood · 21
Relevance of antiphospholipid antibody profile in the clinical outcome of ITP: a single-centre study
2018 · Luca Frison, Annamaria Lombardi, et al. · Hematology · 19
PDF
Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients
2018 · Mario Tiribelli, Massimiliano Bonifacio, et al. · Oncotarget · 19
PDF
Safety and efficacy of switching from branded to generic imatinib in chronic phase chronic myeloid leukemia patients treated in Italy
2018 · Massimiliano Bonifacio, Luigi Scaffidi, et al. · Leukemia Research · 17
Pancreas preservation with Celsior solution in a pig autotransplantation model: comparative study with University of Wisconsin solution
2001 · N Baldan, P Rigotti, et al. · Transplantation Proceedings · 17
MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL
2021 · Manuela Tosi, Orietta Spinelli, et al. · Cancers · 11
PDF
A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements
2024 · Massimiliano Bonifacio, Luigi Scaffidi, et al. · Blood Cancer Journal · 10
PDF
Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response
2015 · Massimiliano Bonifacio, Gianni Binotto, et al. · Haematologica · 10
PDF
Comparative Analysis of NK Receptor and T-Cell Receptor Repertoires in Patients with Chronic Myeloid Leukemia Treated with Different Tyrosine Kinase Inhibitors
2014 · Gianni Binotto, Luca Frison, et al. · Blood · 8
Chronic Myeloid Leukemia With Myelofibrosis-Like Features. Clues of Accelerated Phase?
2019 · Gianni Binotto, Roberta Bertorelle, et al. · International Journal of Surgical Pathology · 2
One Size Does Not Fit to All: Intolerant or Resistant CML Patients Could Benefit from Different Ponatinib Starting Dose Strategies. Multicenter Italian Experience
2018 · Gianni Binotto, Fausto Castagnetti, et al. · Blood · 2
BCR-ABL fusion transcript b2a2 is associated with a higher risk of non-optimal early response in CP-CML patients treated with standard dose imatinib: a study from Gruppo Triveneto LMC.
2016 · Gianni Binotto, Mario Tiribelli, et al. · 2
Generic Versus Branded Imatinib As Frontline Therapy in Chronic-Phase Chronic Myeloid Leukemia Patients in Italy: A Case-Control Study
2019 · Massimiliano Bonifacio, Mario Tiribelli, et al. · Blood · 1
Bartonella henselae infection associated with a multisystemic thrombo-inflammatory syndrome in an immunocompetent adult
2026 · Giovanni Gobbo, Marco Zacchia, et al. · Infection
Mynerva-gimema AML1919 ameliorate Trial: EARLY intensification in FLT3-mutated ACUTE myeloid leukemia based on peripheral blast clearance
2025 · Francesco Mannelli, Giacomo Gianfaldoni, et al. · Blood
PDF
S298: Maternal and Fetal Outcomes in Pregnancies of Women With Immune Thrombocytopenia: a Multicenter Retrospective Observational Itp-net Italian Study
2023 · Monica Carpenedo, Antonella Poloni, et al. · HemaSphere
Necrotizing Follicular Lymphoma of the Inguinal Region with Sternbergoid Cells: Clinical–Pathological Features of a Challenging Entity
2022 · Federico Scarmozzino, Marco Pizzi, et al. · Applied Sciences
PDF
Acute undifferentiated/unclassifiable leukemia or disseminated non-hematologic neoplasm? When treatment is the compelling decision
2021 · UOC Ematologia, Ospedale dell’Angelo, Mestre Venezia, Italy, Luca Frison, et al. · Journal of Clinical Images and Medical Case Reports
PDF
Pb1930 Correlation Between Levels of Early Molecular Response and Bcr-abl Transcript Type in Stable Dmr Attainment in Cml Patients Treated With Imatinib
2019 · M. Tiribelli, M. Bonifacio, et al. · HemaSphere
Incidence, Risk Factors, Impact of Infections on Outcome of MDS, CMML and AML Patients Treated with Azacitidine: Single Centre Experience
2017 · E. De March, G. Binotto, et al. · Leukemia Research
Similar Efficacy of Dasatinib and Nilotinib As Second-Line Therapy in Patients with Chronic Phase Chronic Myeloid Leukemia Failing Imatinib: A Retrospective, Real-Life Study
2016 · Mario Tiribelli, Massimiliano Bonifacio, et al. · Blood
Works count: 31
Citation count: 376
H-index: 10
I10-index: 12
Year
Topic
Type